Smith R L, Geller A I, Escudero K W, Wilcox C L
Department of Neurology and Pediatrics, University of Colorado Health Sciences Center, Denver, USA.
J Virol. 1995 Aug;69(8):4593-9. doi: 10.1128/JVI.69.8.4593-4599.1995.
Amplicons, defective herpes simplex virus type 1 (HSV-1) vectors, were constructed to use four HSV-1 promoters, from the immediate-early (IE) 1 IE 3, IE 4/5, and late glycoprotein C (gC) genes, to regulate expression of the Escherichia coli lacZ gene, encoding beta-galactosidase, and packaged into infectious particles. Infection of sensory neurons in vitro with amplicons containing the IE 1, IE 3, or IE 4/5 promoter resulted in stable long-term expression of beta-galactosidase from 2 to 10 weeks after gene transfer. The number of neurons expressing beta-galactosidase was not changed by treatments previously shown to produce reactivation of latent HSV-1. In addition, the latency-associated transcript was detected in many of the same neurons that expressed beta-galactosidase, indicating that the viral IE promoters in the amplicons can function in the same neurons that harbor latent virus. Delivery of beta-galactosidase protein directly into neurons by microinjection indicated that the half-life for histochemical detection of beta-galactosidase was between 24 and 48 h, suggesting that the persistence of beta-galactosidase histochemical staining cannot be explained by the stability of the reporter protein alone. In contrast to the IE promoters, the gC promoter of the late gene class did not support long-term expression of beta-galactosidase; instead, beta-galactosidase was detected in only a few neurons per culture at 2 weeks after infection, and superinfection with wild-type HSV-1 did not increase the level of expression from the gC promoter. These results suggest that the HSV-1 IE promoters in the amplicons are not subject to the promoter inactivation that occurs with many types of virus vectors and that the IE promoters in the context of the amplicon avoid the promoter inactivation observed from the same promoters in the HSV-1 genome during latency.
构建了扩增子,即缺陷型单纯疱疹病毒1型(HSV-1)载体,以使用来自立即早期(IE)1、IE 3、IE 4/5和晚期糖蛋白C(gC)基因的四个HSV-1启动子来调控编码β-半乳糖苷酶的大肠杆菌lacZ基因的表达,并将其包装成感染性颗粒。用含有IE 1、IE 3或IE 4/5启动子的扩增子体外感染感觉神经元,导致基因转移后2至10周β-半乳糖苷酶稳定长期表达。表达β-半乳糖苷酶的神经元数量并未因先前显示可产生潜伏性HSV-1再激活的处理而改变。此外,在许多表达β-半乳糖苷酶的相同神经元中检测到了潜伏相关转录本,这表明扩增子中的病毒IE启动子可在携带潜伏病毒的相同神经元中发挥作用。通过显微注射将β-半乳糖苷酶蛋白直接递送至神经元表明,β-半乳糖苷酶组织化学检测的半衰期在24至48小时之间,这表明β-半乳糖苷酶组织化学染色的持续性不能仅由报告蛋白的稳定性来解释。与IE启动子相反,晚期基因类别的gC启动子不支持β-半乳糖苷酶的长期表达;相反,感染后2周时,每培养物中仅在少数神经元中检测到β-半乳糖苷酶,用野生型HSV-1进行超感染并未增加gC启动子的表达水平。这些结果表明,扩增子中的HSV-1 IE启动子不会受到许多类型病毒载体所发生的启动子失活的影响,并且在扩增子背景下的IE启动子避免了在潜伏期HSV-1基因组中相同启动子所观察到的启动子失活。